Xueying An

机构：China Pharmaceutical University, National Clinical Research Center for Digestive Diseases, Anhui Academy of Agricultural Sciences, Nanjing Drum Tower Hospital, Shanghai Pesticide Research Institute, National Clinical Research, Second Affiliated Hospital of Nanjing Medical University, Beijing Children’s Hospital, Pharmaceutical Biotechnology (Czechia), State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University · ORCID：0009-0002-0882-623X

发表论文 29 篇 · 总被引 663 次 · h-index 15

代表论文

• In situ modification of ZIF-67 with multi-sulfonated dyes for great enhanced methylene blue adsorption via synergistic effect (2020 · Microporous and Mesoporous Materials · 被引 73)
• Synthesis-temperature-regulated multi-enzyme-mimicking activities of ceria nanozymes (2021 · Journal of Materials Chemistry B · 被引 70)
• Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus (2025 · Bone Research · 被引 45)
• Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance (2020 · Nanoscale · 被引 41)
• Adhesive Nanoparticle‐in‐Microgel System with ROS Scavenging Capability and Hemostatic Activity for Postoperative Adhesion Prevention (2024 · Small · 被引 30)
• The Effect of Ball Milling Time on the Isolation of Lignin in the Cell Wall of Different Biomass (2021 · Frontiers in Bioengineering and Biotechnology · 被引 28)